Saving Self - Drug Discovery & Development

Saving SelfDrug Discovery & Development, NJ - 21 hours ago(Source: Bristol-Myers Squibb). into years of pain. “Imagine pebbles in your shoes that you can’t take out,” Robson says. “Try walking on them all day. …

Read full story

Goldman Changes Its Rx For Bristol-Myers, Forest Labs - Forbes

Goldman Changes Its Rx For Bristol-Myers, Forest LabsForbes, NY - 22 hours agoSeparately, Kelly told clients that the shares of Bristol-Myers Squibb appear rich on fundamentals. The analyst said that he believes that management has …Ahead of the Bell: Forest Labs Forbesall 4 news articles

Read full story

Behind the Headlines: Bristol-Myers Squibb (BMY) Slips Sideways on … - Schaeffers Research

Behind the Headlines: Bristol-Myers Squibb (BMY) Slips Sideways on …Schaeffers Research, OH - 21 hours agoAppearing in part 2 of today's "Behind the Headlines" is Bristol-Myers Squibb (BMY). Bristol-Myers Squibb (BMY): This morning, Goldman Sachs cut its rating …

Read full story

Bristol-Myers Squibb Paid Lobbyist $120K - Houston Chronicle

Bristol-Myers Squibb Paid Lobbyist $120KHouston Chronicle, United States - Aug 27, 20072007 AP WASHINGTON — Drug developer Bristol-Myers Squibb Co. paid the Nickles Group $120000 to lobby the federal government in the first half of 2007, …

Read full story

Is Yahoo!-Microsoft Still Alive? - TheStreet.com

Is Yahoo!-Microsoft Still Alive?TheStreet.com - 23 hours agoAnalyst Downgrades: Goldman Sachs downgraded Bristol-Myers Squibb (BMY - Cramer's Take - Stockpickr) to sell from neutral and lowered its price target to …Bristol-Myers Squibb - Google News

Read full story

Lilly's target - Indianapolis Star

Lilly's targetIndianapolis Star, United States - Sep 1, 2007Bristol-Myers Squibb, maker of Plavix, declined to speculate on the outcome, taking a wait- and-see approach to the data results. …

Read full story

Bristol-Myers Squibb paid lobbyist $360K - CNNMoney.com

Bristol-Myers Squibb paid lobbyist $360KCNNMoney.com - Aug 28, 2007They must register with Congress within 45 days of being hired or engaging in lobbying. Bristol-Myers Squibb is based in New York City.

Read full story

Bristol-Myers Squibb Paid Lobbyist $360K - Forbes

Bristol-Myers Squibb Paid Lobbyist $360KForbes, NY - Aug 28, 2007AP 08.28.07, 12:59 PM ET Drug developer Bristol-Myers Squibb Co. paid Patton Boggs LLP $360000 to lobby the federal government in the first half of 2007, …

Read full story

Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide … - CNNMoney.com

Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide …CNNMoney.com - Aug 27, 2007"Pfizer's agreement with Bristol-Myers Squibb reflects our efforts to build external alliances and share resources to address significant areas of unmet …

Read full story

Dow Foam Granulation Technology Licensed to Bristol-Myers Squibb … - WebWire (press release)

Dow Foam Granulation Technology Licensed to Bristol-Myers Squibb …WebWire (press release), GA - Aug 31, 2007Dow Wolff Cellulosics, a business unit of The Dow Chemical Company, today announced a commercial contract with Bristol-Myers Squibb (NYSE: BMY) to use Dow’s …

Read full story

Bristol-Myers Squibb Paid Lobbyist $120K - Forbes

Bristol-Myers Squibb Paid Lobbyist $120KForbes, NY - Aug 27, 2007AP 08.27.07, 12:03 PM ET Drug developer Bristol-Myers Squibb Co. paid the Nickles Group $120000 to lobby the federal government in the first half of 2007, …

Read full story

Zacks Analyst Blog Highlights: OSI Pharmaceuticals, Merck … - Business Wire (press release)

Zacks Analyst Blog Highlights: OSI Pharmaceuticals, Merck …Business Wire (press release), CA - Aug 31, 2007Stocks recently featured in the blog include: OSI Pharmaceuticals, Inc. (Nasdaq: OSIP), Merck (NYSE: MRK), Novartis (NYSE: NVS), Bristol-Myers Squibb (NYSE: …

Read full story

Thailand to buy generic rivals to Sanofi-Aventis', Bristol-Myers … - Forbes

Thailand to buy generic rivals to Sanofi-Aventis', Bristol-Myers …Forbes, NY - Aug 22, 2007BANGKOK (Thomson Financial) - Thailand's army-backed government said it will import generic versions of Sanofi-Aventis' and Bristol-Myers Squibb Co's heart …

Read full story

Social Conscience Led GC to Bristol-Myers Squibb - Law.com (subscription)

Social Conscience Led GC to Bristol-Myers SquibbLaw.com (subscription), CA - Aug 27, 2007Company Profile: Bristol-Myers Squibb Co. operates in more than 100 countries, selling prescription medications for heart disease, high cholesterol, cancer, …

Read full story

Pfizer, Bristol-Myers Squibb Announce Global Collaboration - NJBIZ

NJBIZPfizer, Bristol-Myers Squibb Announce Global CollaborationNJBIZ, NJ - Aug 27, 2007Shares of Pfizer were flat at $24.74 late this morning; Bristol-Myers Squibb was trading at $29.68, up from Friday’s close of $29.55.Bristol-Myers Squibb - Google News

Read full story

Fitch Affirms Bristol-Myers Squibb's 'A+' IDR & Removes Rating … - Business Wire (press release)

Fitch Affirms Bristol-Myers Squibb's 'A+' IDR & Removes Rating …Business Wire (press release), CA - Aug 3, 2007CHICAGO–(BUSINESS WIRE)–Fitch Ratings has affirmed Bristol-Myers Squibb's (Bristol-Myers) ratings and simultaneously removed the ratings from Rating Watch …

Read full story

Bristol-Myers Squibb And ImClone Systems Significantly Expand … - Medical News Today (press release)

Bristol-Myers Squibb And ImClone Systems Significantly Expand …Medical News Today (press release), UK - 8 hours agoDevelopment costs, up to a threshold value, will be the sole responsibility of Bristol-Myers Squibb; costs in excess of this threshold will be shared by …

Read full story

Pharma Sector: Few Newsmakers Of The Week - Glaxo, Iomai, Bristol … - RTT News

RTT NewsPharma Sector: Few Newsmakers Of The Week - Glaxo, Iomai, Bristol …RTT News, NY - 7 hours agoThursday, Britain's National Institute for Health and Clinical Excellence known as NICE, ruled out Bristol-Myers-Squibb Co.'s (BMY) arthritis drug Orencia …Pharma Sector: Few Newsmakers Of The Week - Glaxo, Iomai, Bristol … Trading Marketsall 2 news articles

Read full story

UK body says Bristol-Myers Orencia drug too costly - Reuters.uk

UK body says Bristol-Myers Orencia drug too costlyReuters.uk, UK - Aug 1, 2007By Michael Kahn LONDON, Aug 2 (Reuters) - Bristol-Myers Squibb Co.'s (BMY.N: Quote, Profile , Research) rheumatoid arthritis drug Orencia should not be …

Read full story

Bristol-Myers Squibb: Orencia is rejected by NICE in the UK - Pharmaceutical Business Review

Bristol-Myers Squibb: Orencia is rejected by NICE in the UKPharmaceutical Business Review - Aug 3, 2007By James Wentworth The decision by the National Institute for Health and Clinical Excellence to reject Bristol-Myers Squibb's Orencia has dealt a blow to …

Read full story

Next Page »